Status:
RECRUITING
Reducing Urban Cervical Cancer Disparities
Lead Sponsor:
Fox Chase Cancer Center
Collaborating Sponsors:
Rutgers, The State University of New Jersey
Thomas Jefferson University
Conditions:
Cervical Cancer
Papilloma Viral Infection
Eligibility:
FEMALE
18-90 years
Phase:
NA
Brief Summary
This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patien...
Detailed Description
Invasive cervical cancer is preventable with well-established screening and diagnostic tests. However, there is a large and persistent disparity gap in cervical cancer mortality rates among urban, und...
Eligibility Criteria
Inclusion
- 18 to 90 years of age (screening is still recommended for some women over 65-depending on screening and medical history and proceeds until age 90 in the study's clinic recruitment sites),
- referral for colposcopic evaluation at the clinic sites,
- able to communicate with ease in English,
- have a cell phone with texting ability, and
- competent to give consent.
Exclusion
- are pregnant at the time of recruitment,
- display current evidence or have a history of positive invasive carcinoma of the cervix, or
- require follow-up but not a colposcopy.
Key Trial Info
Start Date :
August 28 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
546 Patients enrolled
Trial Details
Trial ID
NCT06416150
Start Date
August 28 2024
End Date
December 1 2027
Last Update
October 26 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers, The State University of New Jersey
New Brunswick, New Jersey, United States, 08901
2
Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107
3
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111